8:30-
10:00

NEW DRUGS OF 2022
The signature MidWinter presentation returns, with a new look and feel, but TONS of vital information.

1. Summarize trends for FDA approved products.
2. Describe indication(s) for each product discussed.
3. List potential adverse reactions for each product discussed.
4. List care considerations for a pharmacist/nurse for each product discussed.

10:15-11:45

DKD IN 2023: AN UPDATE FOR THE CLINICAL PHARMACIST

1. Describe the pathophysiology and epidemiology of diabetic kidney disease (DKD)
2. Apply guideline-directed, evidence-based recommendations to develop a care plan for a complex patient with DKD
3. Discuss strategies to enhance communication with and optimize clinical outcomes for patients with DKD
4. Discuss strategies to enhance clinical communication with other HCPs caring for patients with DKD to impact patient outcomes

12:00-12:45

MANAGEMENT OF CHRONIC KIDNEY DISEASE AND HYPERKALEMIA
(presented by AstraZeneca Pharmaceuticals LP; non-CE program)

1. Understand the risk factors that contribute to the elevated risk for thrombotic cardiovascular events pre- and post-myocardial infarction in patients across the coronary artery disease spectrum.
2. Differentiate oral P2Y12 inhibitors with respect to their clinical pharmacology and examine the select differences between oral antiplatelet therapies.
3. Describe the role of BRILINTA in reducing the risk of cardiovascular events in patients with acute coronary syndrome, history of myocardial infarction, and high-risk coronary artery disease without prior myocardial infarction.

1:00-
2:00

ADVANCES IN DIABETES TECHNOLOGY

1. Describe new technologies for people with diabetes including continuous glucose monitoring, connected insulin pens and corresponding mobile applications.
2. Determine which patients are most appropriate for diabetes technologies.
3. Apply clinical practice pearls and patient education techniques to best support the patients with diabetes using new and evolving diabetes technologies.

2:15-
3:15

PHARMACISTS AS LEADERS
Part 1: Crucial Conversations with Patients and Co-workers

Part 2: Mentoring Leadership: CPA’s Mentorship Program

3:30-
4:30

LAW CE: STATE AND FEDERAL LEGISLATIVE ISSUES, 2023 EDITION

1. Identify state and national initiatives and how they could impact the practice of pharmacy.
2. Recall the Prep Act authorities granted to pharmacists and the impact of the end of the public health emergency declaration.
3. Review state and federal legislation that is pending.
4. Describe the PWWR Portal and its importance to the pharmacy team.

5:00-
6:00

INJECTABLES AND OBESITY

6:00-
7:00

IMMUNIZATION CE: IMMUNIZATION CONUNDRUMS IN THE PHARMACY